Amyloid beta (1-40/42) Mouse Monoclonal Antibody [Clone ID: 9F1]

Specifications

Product Data
Clone Name	9F1
Applications	IF
Recommend Dilution	Immunocytochemistry: 1-10 µg/ml.
Reactivity	Human
Host	Mouse
Clonality	Monoclonal
Immunogen	KLH conjugated C-terminal peptide of Amyloid beta A4 (1-40) and beta A4 (1-42).
Specificity	This antibody interacts with the C-termini of both beta-Amyloid (1-40) and (1-42).
Formulation	PBS containing 0.09% Sodium Azide, PEG and Sucrose. Label: FITC State: Liquid purified IgG fraction.
Concentration	lot specific
Purification	Size Exclusion Chromatography.
Conjugation	FITC
Storage Condition	Store the antibody (aliquote in liquid nitrogen) at -80°C. Avoid repeated freezing and thawing. Thaw aliquots at 37°C. Thawed aliquots may be stored at 4°C up to 3 months.
Background	The beta-amyloid peptide (beta A4), proteolytically released from the amyloid precursor protein (APP), is the principal component of senile plaques in Alzheimer's disease. Cleavage of APP by alpha-secretase or alternatively by beta-secretase leads to generation and extracellular release of soluble APP peptides, S-APP-alpha and S-APP-beta, respectively, and the retention of corresponding membrane-anchored C-terminal fragments, C83 and C99. Subsequent processing of C83 by gamma-secretase yields P3 peptides. This is the major secretory pathway and is nonamyloidogenic. Alternatively, presenilin/nicastrin-mediated gamma-secretase processing of C99 releases the amyloid beta proteins, amyloid-beta 40 (Abeta40) and amyloid-beta 42 (Abeta42), major components of amyloid plaques, and the cytotoxic C-terminal fragments, gamma-CTF(50), gamma-CTF(57) and gamma-CTF(59).
Reference Data

*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.